SCR-LIP-000628 · Claim · JSON legível por máquina →
O diabetes é relatado com menos frequência no lipedema e na distribuição periférica de gordura semelhante à do lipedema do que em grupos de comparação, embora o pareamento por adiposidade seja limitado.
Proposição geral consolidada a partir de 3 claims anteriores de artigo único; o resultado de cada estudo aparece como achado.
Claim em resumo
- Tipo
- associação clínica
- Estado do conhecimento
- Emergente
- Certeza da evidência
- baixa (GRADE)
- Evidência
- 4 fonte(s) · de Amato
- Responde a
- 1 pergunta(s)
- Datas
- 2026-11-20 → 2026-11-20
Evidência estruturada, compilada por máquina — não é um veredito.
Evidência ao longo do tempo
Evidência (4)
- Exploring the Immunological Shield Hypothesis: A Population-Based Exploration of Phenotypic Divergence Between Lipedema and Celiac Disease Autoimmunity — Amato et al. (2026) ✓ verificado — consistente · cross sectional · 2026 · confiança da leitura: high
In a population-based NHANES analysis, the DXA-defined lipedema phenotype was associated with lower diabetes prevalence (1.8% vs 8.1%; OR 0.21; 95%CI 0.08-0.51; p<0.001).
Exploratory cross-sectional population study directly examines whether a peripheral/gynoid (lipedema-like) fat distribution confers metabolic protection, reporting lower HOMA-IR and reduced diabetes prevalence with dose-response; supports t - Lipedema: friend and foe — Torre et al. (2018) ✓ verificado — consistente · case series · 2018 · confiança da leitura: moderate
“Perfil cardiometabólico PROTETOR apesar de IMC obeso médio 35,3±1,7 kg/m²: diabetes apenas 2% (vs. ~10% mulheres NHANES idade-pareada); dislipidemia 11,7% (vs. 33,5%); hipertensão 13% (vs. 32,4% mulheres 40-59 anos)”
Chart review of 46 women with lipedema (mean BMI 35.3): diabetes 2% (vs ~10% in age-matched NHANES women), dyslipidemia 11.7% (vs 33.5%), hypertension 13% (vs 32.4%).
The article describes lipedema as a distinct disorder frequently misdiagnosed as obesity or lymphedema, with characteristic fat distribution, staging, inheritance pattern, and a metabolic profile differing from obesity; supports the affirma - Lipedema: A Disease Triggered by M2 Polarized Macrophages? (2025) ✓ verificado — consistente · review · 2025 · confiança da leitura: high
“Diabetes tipo 2: incidência MENOR em pacientes com lipedema vs. controles femininos BMI-matched — efeito 'protetor' da deposição adiposa subcutânea gluteofemoral”
Review reports lower type 2 diabetes incidence in lipedema than in BMI-matched female controls, plus preserved insulin sensitivity and normal CRP, attributed to protective gluteofemoral fat.
The review explicitly reports lower type 2 diabetes incidence and a favorable metabolic profile in lipedema despite high BMI, describing the gluteofemoral fat deposition as 'protective' — directly affirmative to the question regarding metab - Peripheral fat distribution, the lipedema-associated phenotype, and lower prevalence of cardiometabolic disease in women: a cross-sectional study (NHANES 2011-2018) — Amato ACM, Amato JLS, Benitti DA (2026) ✓ verificado — consistente · cross sectional · n=4986 · 2026 · risco de viés: moderate · confiança da leitura: high
“Diabetes 465 0.17 (0.12-0.25) <0.001”
In 4,986 NHANES women, the DXA peripheral fat phenotype was associated with lower diabetes prevalence (1.8% vs 13.6%; OR 0.17, 95%CI 0.12-0.25, adjusted for body-fat category, age, race/ethnicity and smoking; diabetes = self-report or HbA1c ≥6.5%); cross-sectional.
Overlaps the NHANES 2011-2014 participants of DOI:10.7759/cureus.104222 (same group, similar phenotype): not an independent sample for diabetes.
Contexto (PECO)
Responde a estas perguntas
Lacunas e ressalvas
Histórico de mudanças
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000010
- 2026-11-20 — evidence added · finding from DOI:10.1590/1677-5449.202600752 (supporting)